Caroline E. Rutten

773 total citations
22 papers, 405 citations indexed

About

Caroline E. Rutten is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Caroline E. Rutten has authored 22 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 14 papers in Immunology and 4 papers in Genetics. Recurrent topics in Caroline E. Rutten's work include Hematopoietic Stem Cell Transplantation (12 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (9 papers). Caroline E. Rutten is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (9 papers). Caroline E. Rutten collaborates with scholars based in Netherlands, Switzerland and United Kingdom. Caroline E. Rutten's co-authors include Marieke Griffioen, J.H. Frederik Falkenburg, Simone A.P. van Luxemburg-Heijs, Roel Willemze, Edith D. van der Meijden, Cornelis A.M. van Bergen, Machteld Oudshoorn, Inge Jedema, Arend Mulder and Peter A. von dem Borne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Caroline E. Rutten

20 papers receiving 399 citations

Peers

Countries citing papers authored by Caroline E. Rutten

Since Specialization

Citations

This map shows the geographic impact of Caroline E. Rutten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline E. Rutten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline E. Rutten more than expected).

Fields of papers citing papers by Caroline E. Rutten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline E. Rutten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline E. Rutten. The network helps show where Caroline E. Rutten may publish in the future.

Co-authorship network of co-authors of Caroline E. Rutten

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline E. Rutten. A scholar is included among the top collaborators of Caroline E. Rutten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline E. Rutten. Caroline E. Rutten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Azathioprine/hydroxyurea preconditioning prior to nonmyeloablative matched sibling donor hematopoietic stem cell transplantation in adults with sickle cell disease: A prospective observational cohort study 2024 ·American Journal of Hematology ·(unknown), (unknown), Mette D. Hazenberg, Man Tang, (unknown), (unknown), Charlotte F.J. Van Tuijn, Jean‐Louis Kerkhoffs, Caroline E. Rutten, Sacha Zeerleder, Josu de la Fuente, Bart J. Biemond, Erfan Nur	1
2	Comparison of HiDAC Versus FLAG‐IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High‐Risk Myelodysplastic Syndrome 2024 ·European Journal Of Haematology ·Man Tang, (unknown), (unknown), Jarom Heijmans, Arjan A. van de Loosdrecht, Ellen Meijer, Caroline E. Rutten, Mariëlle J. Wondergem, Jeroen J. W. M. Janssen, Marjolein L. Donker, Mette D. Hazenberg, Sonja Zweegman, Bart J. Biemond, David C. de Leeuw, Erfan Nur	1
3	ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning 2023 ·British Journal of Haematology ·(unknown), David C. de Leeuw, Caroline E. Rutten, Otto Visser, Man Tang, (unknown), (unknown), Bart J. Biemond, Arjan A. van de Loosdrecht, Mette D. Hazenberg, Ellen Meijer, Erfan Nur	2
4	Fusariosis in patients with hematological malignancies: Two case reports 2023 ·Medical Mycology Case Reports ·(unknown), (unknown), Caroline E. Rutten, Caspar J. Hodiamont	0
5	How can we differentiate supratentorial tumor recurrence from postradiation imaging changes in children treated for primary malignant brain tumors? 2023 ·Journal of Neurosurgery Pediatrics ·(unknown), Volodia Dangouloff‐Ros, Liesbeth Cardoen, Caroline E. Rutten, Stéphanie Bolle, Claire Alapetite, R. Lévy, D. Grévent, Jacques Grill, Hervé J. Brisse, François Doz, Thomas Blauwblomme, Kévin Beccaria, (unknown), Charles‐Joris Roux, Pascale Varlet, Christelle Dufour, Stéphanie Puget, Nathalie Boddaert	1
6	GATA2 haploinsufficient patients lack innate lymphoid cells that arise after hematopoietic cell transplantation 2022 ·Frontiers in Immunology ·(unknown), Lisette Krabbendam, Nienke J.E. Haverkate, Sacha Zeerleder, Caroline E. Rutten, Bianca Blom, Hergen Spits, Mette D. Hazenberg	4
7	SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies 2022 ·Seminars in Hematology ·(unknown), (unknown), Caroline E. Rutten, Inger S. Nijhof, Mette D. Hazenberg, Abraham Goorhuis	5
8	Improved T-Cell Chimerism and Successful Withdrawal of Immunosuppression after Non-Myeloablative Stem Cell Transplantation for Sickle Cell Disease with Azathioprine/Hydroxyurea Preconditioning Added to Alemtuzumab/TBI Conditioning 2022 ·Blood ·(unknown), (unknown), Man Tang, (unknown), (unknown), Charlotte F.J. Van Tuijn, Jean‐Louis Kerkhoffs, Caroline E. Rutten, Sacha Zeerleder, Mette D. Hazenberg, Bart J. Biemond, Erfan Nur	1
9	Immunogenicity of a 5‐dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation 2022 ·American Journal of Hematology ·(unknown), (unknown), (unknown), Ellen Meijer, Michael W.T. Tanck, Mette D. Hazenberg, Caroline E. Rutten, Godelieve J. de Bree, Erfan Nur, Bob Meek, Martin P. Grobusch, Abraham Goorhuis	10
10	Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase 2020 ·Frontiers in Immunology ·Anita N. Kremer, (unknown), Ellie G.A. Lurvink, Andreas E. Kremer, Caroline E. Rutten, Cornelis A.M. van Bergen, Sascha Kretschmann, (unknown), (unknown), Daniela Mazzeo, Colin Watts, Andréas Mackensen, J.H. Frederik Falkenburg, Marieke Griffioen	5
11	Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis 2020 ·Clinical Immunology ·(unknown), Godelieve J. de Bree, René E. Jonkers, Joris J. T. H. Roelofs, Ineke J. M. ten Berge, Caroline E. Rutten, Erfan Nur, Taco W. Kuijpers, Mette D. Hazenberg, Sacha Zeerleder	9
12	Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response 2017 ·Journal of Clinical Investigation ·Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Liesbeth C. de Wreede, (unknown), Peter A. von dem Borne, Peter van Balen, Mirjam H.M. Heemskerk, Arend Mulder, (unknown), Marcelo A. Navarrete, (unknown), Caroline E. Rutten, Hendrik Veelken, Inge Jedema, Constantijn J.M. Halkes, Marieke Griffioen, J.H. Frederik Falkenburg	74
13	Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus-Host Disease 2012 ·Biology of Blood and Marrow Transplantation ·Caroline E. Rutten, Simone A.P. van Luxemburg-Heijs, Constantijn J.M. Halkes, Cornelis A.M. van Bergen, Erik W.A. Marijt, Machteld Oudshoorn, Marieke Griffioen, J.H. Frederik Falkenburg	46
14	Alloreactive Effector T Cells Require the Local Formation of a Proinflammatory Environment to Allow Crosstalk and High Avidity Interaction with Nonhematopoietic Tissues to Induce GVHD Reactivity 2012 ·Biology of Blood and Marrow Transplantation ·(unknown), Alwine B. Kruisselbrink, Ekaterina S. Jordanova, Caroline E. Rutten, Peter A. von dem Borne, J.H. Frederik Falkenburg, Inge Jedema	16
15	Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia 2011 ·Leukemia ·Sanja Stevanović, Marieke Griffioen, Bart Nijmeijer, Marianke L.J. van Schie, Anita N. Stumpf, Caroline E. Rutten, Roel Willemze, J.H. Frederik Falkenburg	25
16	High-Throughput Characterization of 10 New Minor Histocompatibility Antigens by Whole Genome Association Scanning 2010 ·Cancer Research ·Cornelis A.M. van Bergen, Caroline E. Rutten, Edith D. van der Meijden, Simone A.P. van Luxemburg-Heijs, Ellie G.A. Lurvink, Jeanine J. Houwing‐Duistermaat, Michel G.D. Kester, Arend Mulder, Roel Willemze, J.H. Frederik Falkenburg, Marieke Griffioen	69
17	HLA-DPB1 Mismatching Results in the Generation of a Full Repertoire of HLA-DPB1-Specific CD4+ T Cell Responses Showing Immunogenicity of all HLA-DPB1 Alleles 2010 ·Biology of Blood and Marrow Transplantation ·Caroline E. Rutten, Simone A.P. van Luxemburg-Heijs, Edith D. van der Meijden, Marieke Griffioen, Machteld Oudshoorn, Roel Willemze, J.H. Frederik Falkenburg	25
18	Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro 2010 ·Blood ·Caroline E. Rutten, Simone A.P. van Luxemburg-Heijs, Edith D. van der Meijden, Marieke Griffioen, Machteld Oudshoorn, Roel Willemze, J.H. Frederik Falkenburg	17
19	HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia 2008 ·Leukemia ·Caroline E. Rutten, Simone A.P. van Luxemburg-Heijs, Marieke Griffioen, Erik W.A. Marijt, Inge Jedema, Mirjam H.M. Heemskerk, E.F.M. Posthuma, Roel Willemze, JH Falkenburg	44
20	Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivity 2008 ·Proceedings of the National Academy of Sciences ·Marieke Griffioen, Edith D. van der Meijden, (unknown), M. Willy Honders, Caroline E. Rutten, Simone A.P. van Luxemburg-Heijs, Peter A. von dem Borne, (unknown), Roel Willemze, J.H. Frederik Falkenburg	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact